Skip to content

Amphastar 制药

US · AMPH #3194 按市值排名
25.87 -0.55 -2.08%
实时 - 追踪5344个代码 - 心跳于24秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期(2026/Q3)披露持股的机构数量增加了1家。
  • 机构持股总比例上升了0.2个百分点。

机构持股

机构持股比例
84.13% +0.17pp
机构数量
266 +1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund53.97%
Private Company17.94%
Individual/Insider10.36%
Hedge Fund8.05%
Public Company2.31%
Government Pension Fund1.17%
Family Office/Trust0.39%
Insurance Company0.24%
Other5.54%

主要股东 截至 2026-03-31

Applied Physics & Chemistry Laboratories, Inc. 16.05% · 6.83M 股
BlackRock 12.28% · 5.22M 股
Yongfeng Zhang 6.28% · 2.67M 股
Dimensional Fund Advisors 5.42% · 2.31M 股
Vanguard Capital Management, LLC 4.01% · 1.71M 股
State Street Global Advisors 3.86% · 1.64M 股
American Century Investment Management 2.77% · 1.18M 股
Ziping Luo 2.62% · 1.11M 股
Marshall Wace LLP 2.51% · 1.07M 股
Geode Capital Management, LLC 2.28% · 969.84K 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 23次买入 · 27次卖出

姓名职务持股比例
Applied Physics & Chemistry Laboratories, Inc. -- 16.05%
Yongfeng Zhang Co-founder, President, CEO, Chief Scientific Officer & Director 6.28%
Ziping Luo Chairman of the Board, Chief Scientist & COO 2.62%
Rong Zhou Senior Executive Vice President of Production 0.48%
Shiren S. Lee Independent Director 0.36%
William Peters CFO, Executive VP of Finance, Treasurer & Director 0.16%
Floyd Petersen Independent Director 0.16%
Jacob Liawatidewi Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director 0.15%
Michael Zasloff Independent Director 0.06%
Richard Prins Lead Independent Director 0.05%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-20 William Peters CFO, Executive VP of Finance, Treasurer & Director Automatic Disposition -4,139 $25.00
2026-09-15 Rong Zhou Senior Executive Vice President of Production Derivative Exercise and Sale -10,000 $13.35–23.94
2026-09-01 Rong Zhou Senior Executive Vice President of Production Open Market Disposition -3,187 $23.63
2026-08-31 Rong Zhou Senior Executive Vice President of Production Intent to Sell (Form 144) -13,187 $22.00
2026-08-10 Richard Prins Lead Independent Director Open Market Disposition -7,973 $20.30
2026-08-06 William Peters CFO, Executive VP of Finance, Treasurer & Director Automatic Disposition -3,127 $22.48
2026-08-06 William Peters CFO, Executive VP of Finance, Treasurer & Director Derivative Exercise and Sale -5,053 $19.79–22.48
2026-07-08 Anthony Pierce Independent Director Other Acquisition +7,886 --
2026-07-08 Anthony Pierce Independent Director Other Derivative Acquisition +16,646 $19.02
2026-06-01 Shiren S. Lee Independent Director Sale to Issuer -769 $18.45
2026-05-31 Michael Zasloff Independent Director Other Acquisition +8,143 --
2026-05-31 Michael Zasloff Independent Director Other Derivative Acquisition +17,365 $18.42
2026-05-31 Richard Prins Lead Independent Director Other Acquisition +8,143 --
2026-05-31 Richard Prins Lead Independent Director Other Derivative Acquisition +17,365 $18.42
2026-05-31 Shiren S. Lee Independent Director Other Acquisition +8,143 --
2026-05-31 Shiren S. Lee Independent Director Other Derivative Acquisition +17,365 $18.42
2026-05-31 Gayle Deflin Independent Director Other Acquisition +8,143 --
2026-05-31 Gayle Deflin Independent Director Other Derivative Acquisition +17,365 $18.42
2026-05-31 David Gaugh Director Other Acquisition +8,143 --
2026-05-31 David Gaugh Director Other Derivative Acquisition +17,365 $18.42

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

Amphastar 制药 讨论区 0 条评论

发表评论